表紙
市場調查報告書

寡核苷酸合成的全球市場 - 成長率,趨勢及預測(2019年∼2024年)

Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 649746
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
Back to Top
寡核苷酸合成的全球市場 - 成長率,趨勢及預測(2019年∼2024年) Oligonucleotide Synthesis Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 115 Pages
簡介

全球寡核苷酸合成市場,由於政府的投資及製藥公司和生物科技企業的研究開發費增加,以及分子診斷及臨床應用的合成寡核苷酸的有效利用等要素而成長。

本報告提供全球寡核苷酸合成市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊彙整。

目錄

第1章 簡介

  • 調查的成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 政府投資及製藥、生物科技企業的研究開發費的增加
    • 分子診斷及臨床應用的合成寡核苷酸的有效利用
  • 市場阻礙因素
    • 合成寡核苷酸的價格下降
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/買方議價能力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭激烈度

第5章 市場區隔

  • 各產品類型
    • 合成寡核苷酸生成決裂
    • 各試劑
    • 各設備
  • 各應用領域
    • 各研究
    • 各診斷
    • 各治療
  • 各終端用戶
    • 學術研究機關
    • 製藥、生物科技企業
    • 診斷研究所
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Agilent Technologies
    • Thermo Fisher Scientific
    • Merck KGaA
    • Bio-Synthesis Inc.
    • Eurofins Genomics
    • Eurogentec
    • GE Healthcare
    • GenScript
    • Integrated DNA Technologies Inc.
    • LGC Biosearch Technologies

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 60475

Market Overview

The growth of the oligonucleotide synthesis market is due to the increasing government investments and R&D expenditure in pharmaceutical and biotechnology companies and the use of synthesized oligonucleotides in molecular diagnostics and clinical applications.

The usage of synthetic oligonucleotides has been increasing rapidly over the past decade, owing to several benefits offered by molecular diagnostics and growing clinical applications. The nucleic acid application techniques are the reference methods and are very useful for carrying out the molecular diagnosis in several diseases, like for the detection of infectious diseases, such as hepatitis.

Synthetic oligonucleotides also have significant clinical applications, primarily for the detection of autoimmune antibodies. There have been consistent developments in synthetic biology over the past few years, where synthetic oligonucleotides were used to develop assays for the detection of anti-double-stranded DNAs. Thus, all these factors are responsible for the growth of the oligonucleotide synthesis market.

In addition, there are also other major factors influencing the market for oligonucleotide synthesis. This includes the increasing advancement in the field of healthcare, increasing demand for innovation in the field of life science and medical academics, increasing investment by the government for the development of genomic technologies, and the increasing demand for oligonucleotide synthesis technologies by the public and private research firms.

Scope of the Report

As per the scope of the report, oligonucleotides are short fragments of nucleic acids that are synthesized using genetic engineering and enzyme chemistry. These are mostly used in laboratories in applications, such as therapeutic, diagnostics, as well as academic and industrial. These are used from initial research and screening through to target validation and drug production. Nowadays, subsequent improvements in oligonucleotide synthesis, amplification, and automation have completely revolutionized biological research. It is also possible to do the customizations and get the required sequence online easily and at the required time. These services vary greatly by the cost of per base pair, error rates, lengths, throughput, etc.

Key Market Trends

Academic Research Institutes are the Largest Segment Under End User that is Expected to Grow in the Forecast Period

The government and private entities are found investing in the development of academic and research infrastructure in the emerging economies. This factor is positively boosting the oligonucleotide adoption in academic research institutes. There is an increase in the genomic research projects conducted by academic research institutes that have enabled the segment to account for the dominant share in the market.

North America is the Largest Growing Segment and is Expected to Follow the Same Trend Over the Forecast Period

North America dominates the market due to the presence of better health care infrastructure and increasing usage of oligonucleotides by pharmaceutical companies of the region. Furthermore, the strong foothold of North America in genomics, proteomics, oncology, diagnostic screening, and drug discovery has significantly contributed to maintaining its large share.

Competitive Landscape

The companies are seen adopting various strategies adopted by the competitors that include the acquisition of players in emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolio that helps to drive the overall market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
    • 4.2.2 The Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
  • 4.3 Market Restraints
    • 4.3.1 Price Erosion of Synthesized Oligonucleotides
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 By Synthesized Oligonucleotide Product
      • 5.1.1.1 Primers
      • 5.1.1.2 Probes
      • 5.1.1.3 Large-scale Synthesis Oligonucleotides
      • 5.1.1.4 Intermediate-scale Synthesis Oligonucleotides
      • 5.1.1.5 Other Synthesized Oligonucleotide Product Types
    • 5.1.2 By Reagents
    • 5.1.3 By Equipment
  • 5.2 By Application
    • 5.2.1 By Research
      • 5.2.1.1 PCR
      • 5.2.1.1.1 QPCR
      • 5.2.1.1.2 Sequencing
      • 5.2.1.1.3 Gene Synthesis
      • 5.2.1.1.4 Other Research Application
    • 5.2.2 By Diagnostics
    • 5.2.3 By Therapeutics
      • 5.2.3.1 RNAi
      • 5.2.3.2 Nucleic Acid Aptamers
      • 5.2.3.3 DNA/Antisense Oligonucleotides
      • 5.2.3.4 Other Therapeutics
  • 5.3 By End User
    • 5.3.1 Academic Research Institutes
    • 5.3.2 Pharmaceutical and Biotechnology Companies
    • 5.3.3 Diagnostic Laboratories
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Thermo Fisher Scientific
    • 6.1.3 Merck KGaA
    • 6.1.4 Bio-Synthesis Inc.
    • 6.1.5 Eurofins Genomics
    • 6.1.6 Eurogentec
    • 6.1.7 GE Healthcare
    • 6.1.8 GenScript
    • 6.1.9 Integrated DNA Technologies Inc.
    • 6.1.10 LGC Biosearch Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top